- JP-listed companies
- ONO PHARMACEUTICAL CO., LTD.
- Income statement
ONO PHARMACEUTICAL CO., LTD.【JP:4528】Income statement
Market cap
¥1.13T
P/E ratio
15.9x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 144,175 | 142,806 | 143,247 | 135,775 | 160,284 | 244,797 | 261,836 | 288,634 | 292,420 | 309,284 | 361,361 | 447,187 | 502,672 | 486,871 |
| Cost of revenue | - | - | - | 35,576 | 41,510 | 63,639 | 62,331 | 83,829 | 79,063 | 85,573 | 93,511 | 110,062 | 127,126 | 147,950 |
| Gross profit | - | - | - | 99,406 | 117,846 | 179,625 | 197,892 | 204,805 | 213,356 | 223,711 | 267,850 | 337,124 | 375,547 | 338,921 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | 29,948 | 26,429 | 14,794 | 30,507 | 72,284 | 60,684 | 62,010 | 77,491 | 98,330 | 103,195 | 141,963 | 159,935 | 59,747 |
| Operating expenses | - | - | - | 86,468 | 95,212 | 132,515 | 152,355 | 70,033 | 67,679 | 69,230 | 77,057 | 89,486 | 100,270 | 125,671 |
| Income before tax | 39,432 | 33,013 | 29,464 | 18,305 | 33,272 | 74,540 | 63,922 | 65,141 | 79,696 | 100,890 | 105,025 | 143,532 | 163,734 | 59,328 |
| Provision for income taxes | - | - | - | 3,891 | 6,481 | 14,920 | 8,233 | 13,462 | 19,808 | 25,392 | 24,340 | 30,619 | 35,694 | 9,163 |
| Net income | 23,649 | 22,927 | 20,344 | 12,976 | 24,979 | 55,793 | 50,284 | 51,539 | 59,704 | 75,425 | 80,519 | 112,723 | 127,977 | 50,047 |
| Earnings per share | 44.61 | 43.25 | 38.38 | 24.48 | 47.13 | 105.27 | 97 | 100.25 | 118.47 | 151.11 | 162.19 | 230.85 | 266.61 | 106.55 |
| Diluted EPS | - | - | - | - | 39.19 | 97.22 | 85.6 | 100.24 | 118.45 | 151.09 | 162.16 | 230.79 | 266.57 | 106.41 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | ||||||
| Dividend per share | 180 | 180 | 180 | 180 | 180 | 40 | 45 | 45 | 45 | 50 | 56 | 70 | 80 | 80 |